HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Inhibition of Oncogenic Transcription Factor REL by the Natural Product Derivative Calafianin Monomer 101 Induces Proliferation Arrest and Apoptosis in Human B-Lymphoma Cell Lines.

Abstract
Increased activity of transcription factor NF-κB has been implicated in many B-cell lymphomas. We investigated effects of synthetic compound calafianin monomer (CM101) on biochemical and biological properties of NF-κB. In human 293 cells, CM101 selectively inhibited DNA binding by overexpressed NF-κB subunits REL (human c-Rel) and p65 as compared to NF-κB p50, and inhibition of REL and p65 DNA binding by CM101 required a conserved cysteine residue. CM101 also inhibited DNA binding by REL in human B-lymphoma cell lines, and the sensitivity of several B-lymphoma cell lines to CM101-induced proliferation arrest and apoptosis correlated with levels of cellular and nuclear REL. CM101 treatment induced both phosphorylation and decreased expression of anti-apoptotic protein Bcl-XL, a REL target gene product, in sensitive B-lymphoma cell lines. Ectopic expression of Bcl-XL protected SUDHL-2 B-lymphoma cells against CM101-induced apoptosis, and overexpression of a transforming mutant of REL decreased the sensitivity of BJAB B-lymphoma cells to CM101-induced apoptosis. Lipopolysaccharide-induced activation of NF-κB signaling upstream components occurred in RAW264.7 macrophages at CM101 concentrations that blocked NF-κB DNA binding. Direct inhibitors of REL may be useful for treating B-cell lymphomas in which REL is active, and may inhibit B-lymphoma cell growth at doses that do not affect some immune-related responses in normal cells.
AuthorsAlan T Yeo, Spandan Chennamadhavuni, Adrian Whitty, John A Porco Jr, Thomas D Gilmore
JournalMolecules (Basel, Switzerland) (Molecules) Vol. 20 Issue 5 Pg. 7474-94 (Apr 23 2015) ISSN: 1420-3049 [Electronic] Switzerland
PMID25915462 (Publication Type: Journal Article, Research Support, N.I.H., Extramural)
Chemical References
  • BCL2L1 protein, human
  • DNA-Binding Proteins
  • Lipopolysaccharides
  • NF-kappa B p50 Subunit
  • Proto-Oncogene Proteins c-rel
  • RELA protein, human
  • Transcription Factor RelA
  • bcl-X Protein
  • calafianin
  • Tyrosine
Topics
  • 3T3 Cells
  • Animals
  • Apoptosis (drug effects)
  • Cell Line, Tumor
  • Cell Proliferation (drug effects)
  • DNA-Binding Proteins (antagonists & inhibitors)
  • Enzyme Activation (drug effects)
  • HEK293 Cells
  • Humans
  • L Cells
  • Lipopolysaccharides
  • Lymphoma, B-Cell (drug therapy)
  • Macrophages (metabolism)
  • Mice
  • NF-kappa B p50 Subunit (antagonists & inhibitors)
  • Phosphorylation (drug effects)
  • Proto-Oncogene Proteins c-rel (antagonists & inhibitors)
  • Transcription Factor RelA (antagonists & inhibitors)
  • Tyrosine (analogs & derivatives, pharmacology)
  • bcl-X Protein (biosynthesis)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: